Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00906490 · ClinicalTrials.gov registry record
Clinical Study of the Intravenous Blood Glucose System in Hospitalized Adult Elective or Non-Emergent Surgery and Medical/Surgical Intensive Care Unit Patients
A clinical trial of Blood Glucose, sponsored by Edwards Lifesciences.
- Completed
- Registry status
- 100
- Enrollment target
- 5
- Study locations
NCT00906490 is a study of Blood Glucose that has completed, run by Edwards Lifesciences. The registered enrollment target is 100 participants, above the 37-participant average among 4 other Blood Glucose trials with a reported enrollment target (170% higher). The trial reports 5 study locations across 5 states.
The verdict
NCT00906490, a study of Blood Glucose, has completed, sponsored by Edwards Lifesciences.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
- 5
- Study locations
Study Summary
The primary objective of this study is to evaluate the performance and safety of the intravenous blood glucose (IVBG) System relative to point of care (POC) meter performance when each method is compared to the Yellow Springs Instrument (YSI) under various conditions in the operating room (OR), ICU and general ward (GW) in subjects undergoing elective or non-emergent surgery as well as subjects admitted to the medical/surgical ICU. POC meter systems are currently used in the hospital environment to measure blood glucose values. The YSI is an accepted reference standard for assessing POC meter accuracy. The secondary objective of this study is to evaluate the performance of the IVBG System as compared with the YSI under various conditions in the operating room (OR), intensive care unit (ICU) and general ward (GW) in subjects undergoing elective or non-emergent surgery as well as subjects admitted to the medical/surgical ICU.
Conditions Studied
Interventions
- DEVICE Intravenous Blood Glucose monitoring system
Study Locations (5)
District of Columbia
- Washington Hospital Center (WHC) - Washington D.C.
Maryland
- University of Maryland School of Medicine - Baltimore
Minnesota
- International Diabetes Center (IDC), Methodist Hospital - Minneapolis
Oregon
- Providence Heart and Vascular Institute - Portland
Pennsylvania
- Thomas Jefferson University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2009-06 |
| Est. Completion | 2010-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00906490
The ClinicalTrials.gov registry entry for NCT00906490 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 37-participant average among 4 other Blood Glucose trials with a reported enrollment target (170% higher). The listed sponsor is Edwards Lifesciences, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Blood Glucose appearing as the primary indexed condition, and to 1 intervention - of which Intravenous Blood Glucose monitoring system is the first listed.
NCT00906490 reports 5 study locations spanning 5 distinct geographic areas - top geographies include District of Columbia, Maryland, Minnesota.
Frequently Asked Questions
What is clinical trial NCT00906490 about?
NCT00906490 is a clinical study titled "Clinical Study of the Intravenous Blood Glucose System in Hospitalized Adult Elective or Non-Emergent Surgery and Medical/Surgical Intensive Care Unit Patients". The primary objective of this study is to evaluate the performance and safety of the intravenous blood glucose (IVBG) System relative to point of care (POC) meter performance when each method is compared to the Yellow Springs Instrument (YSI) under various conditions in the operating room (OR), ICU ...
What is the current status of trial NCT00906490?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2009-06. Estimated completion is 2010-05.
What conditions does trial NCT00906490 study?
This clinical trial studies the following conditions: Blood Glucose.
What interventions are being tested in trial NCT00906490?
The interventions under investigation include: Intravenous Blood Glucose monitoring system (DEVICE).
Who is sponsoring clinical trial NCT00906490?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00906490 being conducted?
This trial has 5 study locations across District of Columbia, Maryland, Minnesota, Oregon, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Glucose
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Postprandial Response to Fruit Juice
RECRUITING · NA
-
Effect of D-allulose in Addition to Oral Sucrose Load
COMPLETED · Phase 2
-
Barley and Rice Mixture Effects on Blood Glucose
COMPLETED · NA
-
A Randomized, Crossover Study to Assess the Effects of Dietary Fiber-containing Bars on Glucose and Insulin Responses
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.